Log In
person
BioCryst Pharmaceuticals Inc
BCRX
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Pharma for Rare Diseases |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
324.7M | 97.97% |
| Pharma for Rare Diseases |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
6.72M | 2.03% |
| keyboard_arrow_down |
Pharma for Rare Diseases
Branded Pharmaceuticals (outsourced)
|
324.7M | 97.97% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Pharma for Rare Diseases
Pharmaceutical Patent Licensing
|
6.72M | 2.03% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||